Artikelen met mandaten voor openbare toegang - Ian BruceMeer informatie
Nergens beschikbaar: 39
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
DJ Wallace, RA Furie, Y Tanaka, KC Kalunian, M Mosca, MA Petri, ...
The Lancet 392 (10143), 222-231, 2018
Mandaten: US National Institutes of Health, National Institute for Health Research, UK
Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus
K McElhone, J Abbott, J Shelmerdine, IN Bruce, Y Ahmad, C Gordon, ...
Arthritis Care & Research 57 (6), 972-979, 2007
Mandaten: Versus Arthritis, UK
Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
S Skeoch, IN Bruce
Nature Reviews Rheumatology 11 (7), 390-400, 2015
Mandaten: Versus Arthritis, UK, UK Medical Research Council, National Institute for …
Environmental risk factors for the development of psoriatic arthritis: results from a case–control study
E Pattison, BJ Harrison, CEM Griffiths, AJ Silman, IN Bruce
Annals of the rheumatic diseases 67 (5), 672-676, 2008
Mandaten: Versus Arthritis, UK
The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review
EJ Sutton, JE Davidson, IN Bruce
Seminars in arthritis and rheumatism 43 (3), 352-361, 2013
Mandaten: Versus Arthritis, UK, Wellcome Trust
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity
A Ippolito, DJ Wallace, D Gladman, PR Fortin, M Urowitz, V Werth, ...
Lupus 20 (3), 250-255, 2011
Mandaten: US National Institutes of Health
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort
MB Urowitz, D Gladman, D Ibanez, P Fortin, J Sanchez‐Guerrero, S Bae, ...
Arthritis Care & Research 59 (2), 176-180, 2008
Mandaten: Canadian Institutes of Health Research
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study
JG Hanly, MB Urowitz, AG O'Keeffe, C Gordon, SC Bae, ...
Arthritis & Rheumatism 65 (11), 2887-2897, 2013
Mandaten: US National Institutes of Health, Canadian Institutes of Health Research …
MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C …
SA Owen, M Lunt, J Bowes, SL Hider, IN Bruce, W Thomson, A Barton
The pharmacogenomics journal 13 (2), 137-147, 2013
Mandaten: Versus Arthritis, UK
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index
M Petri, N Kasitanon, SS Lee, K Link, L Magder, SC Bae, JG Hanly, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
Mandaten: US National Institutes of Health, Canadian Institutes of Health Research
Variants in RUNX3 Contribute to Susceptibility to Psoriatic Arthritis, Exhibiting Further Common Ground With Ankylosing Spondylitis
M Apel, S Uebe, J Bowes, E Giardina, E Korendowych, K Juneblad, ...
Arthritis & Rheumatism 65 (5), 1224-1231, 2013
Mandaten: Versus Arthritis, UK
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
M Petri, IN Bruce, T Dörner, Y Tanaka, EF Morand, KC Kalunian, ...
The Lancet 401 (10381), 1011-1019, 2023
Mandaten: National Institute for Health Research, UK
Vitamin D and systemic lupus erythematosus-The hype and the hope
Y Shoenfeld, R Giacomelli, S Azrielant, O Berardicurti, JA Reynolds, ...
Autoimmunity Reviews 17 (1), 19-23, 2018
Mandaten: Versus Arthritis, UK, UK Medical Research Council, National Institute for …
SLE and metabolic syndrome
B Parker, IN Bruce
Lupus 22 (12), 1259-1266, 2013
Mandaten: Versus Arthritis, UK
The metabolic syndrome in systemic lupus erythematosus
B Parker, IN Bruce
Rheumatic Disease Clinics 36 (1), 81-97, 2010
Mandaten: Versus Arthritis, UK
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 …
EF Morand, RA Furie, IN Bruce, EM Vital, M Dall'Era, E Maho, L Pineda, ...
The Lancet Rheumatology 4 (4), e282-e292, 2022
Mandaten: National Institute for Health Research, UK
Current challenges in the development of new treatments for lupus
M Dall'Era, IN Bruce, C Gordon, S Manzi, J McCaffrey, PE Lipsky
Annals of the rheumatic diseases 78 (6), 729-735, 2019
Mandaten: Versus Arthritis, UK, UK Medical Research Council, National Institute for …
The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease
MA Khamashta, IN Bruce, C Gordon, DA Isenberg, O Ateka-Barrutia, ...
Lupus 23 (3), 273-283, 2014
Mandaten: Wellcome Trust
Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells
JA Reynolds, AC Robertson, IN Bruce, MY Alexander
Pharmacology & therapeutics 142 (2), 231-243, 2014
Mandaten: Versus Arthritis, UK, UK Medical Research Council, National Institute for …
Cognitive dysfunction and functional magnetic resonance imaging in systemic lupus erythematosus
M Barraclough, R Elliott, S McKie, B Parker, IN Bruce
Lupus 24 (12), 1239-1247, 2015
Mandaten: Versus Arthritis, UK, National Institute for Health Research, UK, Wellcome Trust
Publicatie- en financieringsgegevens worden automatisch vastgesteld door een computerprogramma